High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

MLA

Jonathan W. Lischalk, et al. “High-Risk Prostate Cancer Treated with a Stereotactic Body Radiation Therapy Boost Following Pelvic Nodal Irradiation.” Frontiers in Oncology, vol. 14, Feb. 2024. EBSCOhost, https://doi.org/10.3389/fonc.2024.1325200.

APA

Jonathan W. Lischalk, Meredith Akerman, Michael C. Repka, Astrid Sanchez, Christopher Mendez, Vianca F. Santos, Todd Carpenter, David Wise, Anthony Corcoran, Herbert Lepor, Aaron Katz, & Jonathan A. Haas. (2024). High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1325200

Chicago

Jonathan W. Lischalk, Meredith Akerman, Michael C. Repka, Astrid Sanchez, Christopher Mendez, Vianca F. Santos, Todd Carpenter, et al. 2024. “High-Risk Prostate Cancer Treated with a Stereotactic Body Radiation Therapy Boost Following Pelvic Nodal Irradiation.” Frontiers in Oncology 14 (February). doi:10.3389/fonc.2024.1325200.